Rhythm Shukla
Utrecht, UT 3584CS, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Teixobactin: A Resistance-Evading Antibiotic for Treating Anthrax.
Journal: ACS infectious diseases
Published: February 27, 2025
A Resistance-Evading Antibiotic for Treating Anthrax.
Journal: Research square
Published: April 08, 2024
A new antibiotic from an uncultured bacterium binds to an immutable target.
Journal: bioRxiv : the preprint server for biology
Published: June 09, 2023
A novel antifolate suppresses growth of FPGS-deficient cells and overcomes methotrexate resistance.
Journal: Life science alliance
Published: March 24, 2023
An antibiotic from an uncultured bacterium binds to an immutable target.
Journal: Cell
Published: October 10, 2022
Teixobactin kills bacteria by a two-pronged attack on the cell envelope.
Journal: Nature
Published: May 10, 2021
Brevibacillin 2V Exerts Its Bactericidal Activity via Binding to Lipid II and Permeabilizing Cellular Membranes.
Journal: Frontiers in microbiology
Published: April 13, 2021
Brevibacillin 2V, a Novel Antimicrobial Lipopeptide With an Exceptionally Low Hemolytic Activity.
Journal: Frontiers in microbiology
Published: April 11, 2021
Mode of action of teixobactins in cellular membranes.
Journal: Nature communications
Published: February 14, 2020
Showing 1-9 of 9
Last Updated: 09/26/2026